cardiovascular

OMRON Healthcare Unveils Global ECG Strategy

New services and strategic partnerships advance Going for ZERO visionTOKYO, Dec. 11, 2025 /PRNewswire/ -- OMRON Healthcare Co., Ltd. announced…

5 days ago

McLaren Bay Region Raises the Bar on Emergency Department Communication with MEDI+SIGN

BAY CITY, Mich., Dec. 04, 2025 (GLOBE NEWSWIRE) -- McLaren Bay Region has equipped its Emergency Department treatment rooms with…

2 weeks ago

Indian MedTech Company Makes a Global Mark at PCR London Valves 2025

Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25, 2025 /PRNewswire/ -- Underscoring India's rising influence in…

3 weeks ago

Real-World Data Presented at TCT 2025 Demonstrates the EggNest Complete Radiation Protection System Significantly Reduces Radiation Exposure for the Entire Cath Lab Team

SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…

2 months ago

World’s Leading Nutrition Researchers Discuss Future Lines of Research on Nuts and Dried Fruit at NUTS 2025

REUS, Spain, Oct. 22, 2025 /PRNewswire/ -- Leading health researchers from around the world have identified new priorities and directions…

2 months ago

CathWorks Announces Key Events for TCT 2025

The CathWorks FFRangio® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite…

2 months ago

Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza

Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together…

2 months ago

The Hidden Genetic Threat Putting 1 in 5 at Cardiovascular Disease Risk: Global Experts Call for Action on Elevated Lipoprotein(a)

Cardiovascular disease (CVD) kills nearly 18 million people each year, more than all cancers combined1,2Elevated lipoprotein(a) or Lp(a), an inherited condition…

3 months ago

Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas

Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…

4 months ago

Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma’s Energy-Based Technology

CAESAREA, Israel, June 17, 2025 /PRNewswire/ -- A newly published, peer-reviewed study in Nature Scientific Reports, part of the prestigious Nature…

6 months ago